Is angiogenesis essential for the progression of hematological malignancies or is it an epiphenomenon?

Leukemia. 2009 Mar;23(3):433-4. doi: 10.1038/leu.2008.381.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Autocrine Communication
  • Bone Marrow / blood supply
  • Cytokines / physiology
  • Disease Progression
  • Fibroblast Growth Factor 2 / physiology
  • Fibroblast Growth Factor 2 / urine
  • Hematologic Neoplasms / drug therapy
  • Hematologic Neoplasms / physiopathology*
  • Hematologic Neoplasms / urine
  • Humans
  • Lymph Nodes / blood supply
  • Neovascularization, Pathologic / drug therapy
  • Neovascularization, Pathologic / physiopathology*
  • Paracrine Communication

Substances

  • Angiogenesis Inhibitors
  • Cytokines
  • Fibroblast Growth Factor 2